References
1. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke . Feb 2021;16(2):217-221. doi:10.1177/1747493019897870
2. Ganesan AN, Chew DP, Hartshorne T, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J . May 21 2016;37(20):1591-602. doi:10.1093/eurheartj/ehw007
3. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R. Circulation . 2019;140(2)doi:10.1161/cir.0000000000000665
4. Turagam MK, Musikantow D, Whang W, et al. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation. JAMA Cardiology . 2021;6(6):697. doi:10.1001/jamacardio.2021.0852
5. Zhao Y, Krupadev V, Dagher L, et al. Pharmacological rhythm versus rate control in patients with atrial fibrillation and heart failure: the CASTLE-AF trial. J Interv Card Electrophysiol . Sep 2021;61(3):609-615. doi:10.1007/s10840-020-00856-1
6. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation. JAMA . 2019;321(13):1261. doi:10.1001/jama.2019.0693
7. Blomström-Lundqvist C, Gizurarson S, Schwieler J, et al. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation.JAMA . 2019;321(11):1059. doi:10.1001/jama.2019.0335
8. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal . 2021;42(5):373-498. doi:10.1093/eurheartj/ehaa612
9. Gaynor SL, Diodato MD, Prasad SM, et al. A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. The Journal of Thoracic and Cardiovascular Surgery . 2004;128(4):535-542. doi:10.1016/j.jtcvs.2004.02.044
10. Badhwar V, Rankin JS, Damiano RJ, et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. The Annals of Thoracic Surgery . 2017;103(1):329-341. doi:10.1016/j.athoracsur.2016.10.076
11. Ad N, Damiano RJ, Badhwar V, et al. Expert consensus guidelines: Examining surgical ablation for atrial fibrillation. The Journal of Thoracic and Cardiovascular Surgery . 2017;153(6):1330-1354.e1. doi:10.1016/j.jtcvs.2017.02.027
12. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Europace . Jan 1 2018;20(1):157-208. doi:10.1093/europace/eux275
13. McCarthy PM, Davidson CJ, Kruse J, et al. Prevalence of atrial fibrillation before cardiac surgery and factors associated with concomitant ablation. The Journal of Thoracic and Cardiovascular Surgery . 2020;159(6):2245-2253.e15. doi:10.1016/j.jtcvs.2019.06.062
14. Bhargava M, Di Biase L, Mohanty P, et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: Results from a multicenter study. Heart Rhythm . 2009;6(10):1403-1412. doi:10.1016/j.hrthm.2009.06.014
15. Chao T-F, Tsao H-M, Lin Y-J, et al. Clinical Outcome of Catheter Ablation in Patients With Nonparoxysmal Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology . 2012;5(3):514-520. doi:10.1161/circep.111.968032
16. Mansour M, Calkins H, Osorio J, et al. Persistent Atrial Fibrillation Ablation With Contact Force-Sensing Catheter: The Prospective Multicenter PRECEPT Trial.JACC Clin Electrophysiol . Aug 2020;6(8):958-969. doi:10.1016/j.jacep.2020.04.024
17. Su WW, Reddy VY, Bhasin K, et al. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial.Heart Rhythm . 2020;17(11):1841-1847. doi:10.1016/j.hrthm.2020.06.020
18. Tsai T-Y, Lo L-W, Cheng W-H, et al. 10-Year Outcomes of Patients With Non-Paroxysmal Atrial Fibrillation Undergoing Catheter Ablation. Circulation Journal . 2022;doi:10.1253/circj.cj-22-0062
19. Shrestha S, Plasseraud KM, Makati K, et al. Hybrid Convergent ablation for atrial fibrillation: A systematic review and meta-analysis. Heart Rhythm O2 . Aug 2022;3(4):396-404. doi:10.1016/j.hroo.2022.05.006
20. Mannakkara NN, Porter B, Child N, et al. Convergent Ablation for Persistent Atrial Fibrillation: Outcomes from a Single-Center Real-world Experience. Eur J Cardiothorac Surg . Nov 8 2022;doi:10.1093/ejcts/ezac515
21. Wats K, Kiser A, Makati K, et al. The Convergent Atrial Fibrillation Ablation Procedure: Evolution of a Multidisciplinary Approach to Atrial Fibrillation Management.Arrhythm Electrophysiol Rev . Aug 2020;9(2):88-96. doi:10.15420/aer.2019.20
22. Kress DC. Characterizing Recurrence Following Hybrid Ablation in Patients With Persistent Atrial Fibrillation. Journal of Patient-Centered Research and Reviews . 2020;7(3):227-238.
23. Makati KJ, Sherman AJ, Gerogiannis I, Sood N. Safety and Efficacy of Convergent Hybrid Procedure Using Cryo as Endocardial Energy Source for the Treatment of Atrial Fibrillation. Circ Arrhythm Electrophysiol . Nov 2020;13(11):e008556. doi:10.1161/CIRCEP.120.008556
24. DeLurgio DB, Crossen KJ, Gill J, et al. Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation: Results of CONVERGE Clinical Trial. Circ Arrhythm Electrophysiol . Dec 2020;13(12):e009288. doi:10.1161/CIRCEP.120.009288
25. Yang F, Tiano J, Mittal S, Turakhia M, Jacobowitz I, Greenberg Y. Towards a Mechanistic Understanding and Treatment of a Progressive Disease: Atrial Fibrillation. Journal of Atrial Fibrillation . 2017;10(3)doi:10.4022/jafib.1627
26. Tilz RR, Rillig A, Thum A-M, et al. Catheter Ablation of Long-Standing Persistent Atrial Fibrillation.Journal of the American College of Cardiology . 2012;60(19):1921-1929. doi:10.1016/j.jacc.2012.04.060
27. Clarnette JA, Brooks AG, Mahajan R, et al. Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis.Europace . Nov 1 2018;20(FI_3):f366-f376. doi:10.1093/europace/eux297
28. Delurgio DB, Blauth C, Halkos ME, et al. Hybrid epicardial-endocardial ablation for long-standing persistent atrial fibrillation: a subanalysis of the CONVERGE trial.Heart Rhythm O2 . 2022;doi:10.1016/j.hroo.2022.11.007
29. Maclean E, Yap J, Saberwal B, et al. The convergent procedure versus catheter ablation alone in longstanding persistent atrial fibrillation: A single centre, propensity-matched cohort study. International Journal of Cardiology . 2020;303:49-53. doi:10.1016/j.ijcard.2019.10.053
30. Zhuang J, Wang Y, Tang K, et al. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. Europace . May 2012;14(5):638-45. doi:10.1093/europace/eur364
31. Njoku A, Kannabhiran M, Arora R, et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace . Jan 1 2018;20(1):33-42. doi:10.1093/europace/eux013
32. DeLurgio DB, Gill JS, Ahsan S, Kaba RA, Plasseraud KM, Halkos ME. Hybrid Convergent Procedure for the Treatment of Persistent and Long-standing Persistent Atrial Fibrillation. Arrhythm Electrophysiol Rev . Oct 2021;10(3):198-204. doi:10.15420/aer.2021.24
33. Santhanakrishnan R, Wang N, Larson MG, et al. Atrial Fibrillation Begets Heart Failure and Vice Versa. Circulation . 2016;133(5):484-492. doi:10.1161/circulationaha.115.018614
34. Anter E, Jessup M, Callans DJ. Atrial Fibrillation and Heart Failure. Circulation . 2009;119(18):2516-2525. doi:10.1161/circulationaha.108.821306
35. Noseworthy PA, Van Houten HK, Gersh BJ, et al. Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice. Heart Rhythm . Jul 2020;17(7):1057-1065. doi:10.1016/j.hrthm.2020.02.030
36. Marrouche NF, Brachmann J, Andresen D, et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. New England Journal of Medicine . 2018;378(5):417-427. doi:10.1056/nejmoa1707855
37. Kiankhooy A, Pierce C, Burk S, Phillips A, Eisenberg S, Dunnington G. Hybrid Ablation of Persistent and Long-Standing Persistent Atrial Fibrillation with Depressed Ejection Fraction: A Single Center Observational Study. JTCVS Open . 2022;doi:10.1016/j.xjon.2022.08.014
38. Di Biase L, Burkhardt JD, Mohanty P, et al. Left Atrial Appendage. Circulation . 2010;122(2):109-118. doi:10.1161/circulationaha.109.928903
39. Lee LS. Subxiphoid Minimally Invasive Epicardial Ablation (Convergent Procedure) With Left Thoracoscopic Closure of the Left Atrial Appendage. Operative Techniques in Thoracic and Cardiovascular Surgery . December 1, 2018 2019;23(4):152-165. doi:https://doi.org/10.1053/j.optechstcvs.2019.04.002
40. Ranjan R, Kaba R, Chandrasekaran V, Momin A. The Convergent Ablation and AtriClip Exclusion of the Left Atrial Appendage in Long-Standing Persistent Atrial Fibrillation.Clinical Medicine Insights: Case Reports . 2022;15:117954762211207. doi:10.1177/11795476221120778
41. Gegechkori N. The Effect of Left Atrial Appendage Closure on Patients Undergoing Hybrid / Convergent Atrial Fibrillation Ablation. Original Research. Journal of Atrial Fibrillation & Electrophysiology . June-July 2022 2022;15(4):66-71.
42. Marshall J. On the Development of the Great Anterior Veins in Man and Mammalia; Including an Account of Certain Remnants of Foetal Structure Found in the Adult, a Comparative View of These Great Veins in the Different Mammalia, and an Analysis of Their Occasional Peculiarities in the Human Subject. Philosophical Transactions of the Royal Society of London . 1850;140:133-170.
43. Rodríguez-Mañero M, Schurmann P, Valderrábano M. Ligament and vein of Marshall: A therapeutic opportunity in atrial fibrillation. Heart Rhythm . 2016;13(2):593-601. doi:10.1016/j.hrthm.2015.10.018
44. Jiang R-H. Marked Suppression of Pulmonary Vein Firing After Circumferential Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation: Is Pulmonary Vein Firing an Epiphenomenon? Original Article. Journal of Cardiovascular Electrophysiology . 2014;25(2):111-118. doi:https://doi.org/10.1111/jce.12288
45. Katritsis DG, Pokushalov E, Romanov A, et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. J Am Coll Cardiol . Dec 17 2013;62(24):2318-25. doi:10.1016/j.jacc.2013.06.053
46. Wong CX, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J . May 1 2017;38(17):1294-1302. doi:10.1093/eurheartj/ehw045
47. Valderrábano M, Peterson LE, Swarup V, et al. Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation. JAMA . 2020;324(16):1620. doi:10.1001/jama.2020.16195
48. Kumar P, Bamimore AM, Schwartz JD, et al. Challenges and Outcomes of Posterior Wall Isolation for Ablation of Atrial Fibrillation. Journal of the American Heart Association . 2016;5(9):e003885. doi:10.1161/jaha.116.003885
49. Pothineni NVK, Lin A, Frankel DS, et al. Impact of left atrial posterior wall isolation on arrhythmia outcomes in patients with atrial fibrillation undergoing repeat ablation. Heart Rhythm O2 . 2021;2(5):489-497. doi:10.1016/j.hroo.2021.07.004